MCD three-lens brief
Evidence-based stock research on MCD. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 24.1pp over 30 days. · Trading at 8% of its 52-week range — deep in the lower band.
- Trading at 8% of its 52-week range — deep in the lower band.
- RSI at 30 — technically oversold.
- Underperforming SPY by 24.1pp over 30 days.
- Analyst mean target $331.21 — 19% above current (33 analysts).
MCD closed at $277.25 (+0.88%) as of 2026-05-13. Market cap: $196.99B. P/E (trailing) 22.9. Positives: analyst mean target $331.21 — 19% above current (33 analysts).. Concerns: trading at 8% of its 52-week range — deep in the lower band.; rSI at 30 — technically oversold.. Last quarter: Revenue $7.01B, net income $2.16B, free cash flow $6.30B.
Why three lenses on MCD, not one.
A single reasoning model has blind spots it doesn’t know about. We examine MCDacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/MCD" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath MCD brief"></iframe>